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 Thalassemias are hemoglobinopathies and are hereditary deseases which are characterized by disturbance in synthesis of one or more 
polypeptide chains of globin. Thalassemias are type of anemia of quantitative nature, where synthesized chain of hemoglobin are with normal 
structure, but not in adequate quantities. β-thalassemia is a desease characterized by production of large quantities of α-chains which exceedes 
the production of β-chains, whereas β-chains accumulate and precipitate into precursors of red blood cells and change their permeability, which 
leads to lysis of red blood cells. Within Research Center for Genetic Engineering and Biotechnology (RCGEB) is operating national reference 
laboratory for hemoglobinopathies, founded in 1970, where over the past 40 years examined more than 30,000 individuals from our country. The 
analysis revealed that the average frequency of beta-thalassemia in Macedonia is 2.6%, of alpha thalassemia is 1.5%, delta-beta-thalassemia is 
0.2%, while the share of Swiss type of hereditary persistence of fetal hemoglobin (HPFH) is 0.3%.  
 AIM OF THE STUDY 
 
The objective of this study was to show the prevalence, or the 
presence, of a certain type of thalassemia in the region of Strumica, R. 
of Macedonia, the complications that arise in specific cases, and the 
diagnosis and treatment of this inherited disease, not only for 
successfully identifying the extent of the presence of thalassemias in 
this region, but also to display the patient status in this region. 
 
MATERIAL AND METHODS 
 
The target group for this research were registered patients with 
thalassemia from the region of Strumica. For that purpose, we 
processed medical histories of 29 subjects suffering from some type 
of thalassemia. All subjects which entered in this study  were 
respectively coded in order to avoid violation of their privacy and 
were randomly selected. 
 
As a material for the research we used data from medical histories of 
the subjects of interest, and subsequently analyzed those data. Of all 
data we selected those who are significant for our research like 
geographical location, sex, age, type of thalassemia, blood tests 
values, comorbidities and complications from the desease. 
RESULTS AND DISCUSSION 
 
Analysis of the available data shows that the most of the patients 
had or have β-thalassemia type minor, followed by patients with 
β-thalassemia type major, then α-thalassemia, and only 2 
patients with β-thalassemia intermedia (Figure 1). 
As far as geographical location we can conclude that the most of 
the patient came from the city of Strumica, while other patients 
are from rural suburbs of Strumica (Figure 2). 
As suspected, all significant blood parameters which are 
characteristic for thalassemias, such as Hgb, Er, MCV, MCH, 
HbF, HbA2, AST, ALT, and others, shows deviation from normal 
ranges. 
Also we found a lot of comorbidities and complication associated 
with β-thalassemias (Figure 3). 
All patients were treated with standard therapeutical agents and 
procedures, such as iron chelating agents, iron supplements and 
therapy with washed and filtered red blod cells. 
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FIGURE 1. 
Patients with some type of thalassemia 
in the region of Strumica
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FIGURE 2. 
Geographical distribution of patients with some type of 
thalassemia
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FIGURE 3.
Comorbidities and complication from β-thalassemias
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CONCLUSION 
 
The data analysis indicates the presence of many characteristic 
sympthoms and clinical manifestation of many features of 
thalassemias, which confirms the theoretical framework for this 
hemoglobinopathy.  
In many patients it is observed decline in values of hemoglobin, 
reduces number of red blood cells, and disruption of liver 
function, followed by decreased function of liver enzymes. 
Therapy that is administered to the patients is of basic character, 
a continuous blood transfusion in patients with milder form of 
thalassemia, and excess iron chelators, whilst in the patients 
with severe forms of thalassemia spelenctomy was performed.  
The results shows that the experimental group of patients 
present many comorbidities and complications thay complays 
with the medical theory about thalassemias. 
